Current Approach to the Diagnosis and Treatment of Heterozygote and Homozygous FH Children and Adolescents

Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry

(2020) Luirink Ik et al.   ATHEROSCLEROSIS

Nine-year overview of dyslipidemia management in children with heterozygous familial hypercholesterolemia: a university hospital outpatient lipid clinic project in Northwestern Greece

(2020) Thomas Benekos et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia

(2020) Claudia Stefanutti   Current Atherosclerosis Reports

Hyperlipidemia

(2020) Jeremy Stewart et al.   PEDIATRICS IN REVIEW

Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care

(2020) Sujana Balla et al.   Current Atherosclerosis Reports

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia

(2020) Raul D. Santos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evinacumab for Homozygous Familial Hypercholesterolemia

(2020) Frederick J. Raal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lipoprotein Apheresis and PCSK9-Inhibitors. Impact on Atherogenic Lipoproteins and Anti-Inflammatory Mediators in Familial Hypercholesterolaemia

(2019) Claudia Stefanutti et al.   CURRENT PHARMACEUTICAL DESIGN

Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events

(2019) Jane Armitage et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia

(2019) Tawfeg Ben-Omran et al.   ADVANCES IN THERAPY

A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolaemia: the Sino-Roman Study

(2019) Claudia Stefanutti et al.   Journal of Clinical Lipidology

Screening and management of familial hypercholesterolemia

(2019) Raul D. Santos   CURRENT OPINION IN CARDIOLOGY

Lomitapide and Mipomersen—Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis

(2019) Dirk J. Blom et al.   Current Atherosclerosis Reports

Inclisiran—New hope in the management of lipid disorders?

(2019) Krzysztof Dyrbuś et al.   Journal of Clinical Lipidology

20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia

(2019) Ilse K. Luirink et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report

(2018) M. G. Zenti et al.   JOURNAL OF CLINICAL APHERESIS

Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia

(2018) Merel L. Hartgers et al.   Journal of Clinical Lipidology

Statins: pros and cons

(2018) Iago Pinal-Fernandez et al.   MEDICINA CLINICA

Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity

(2018) Günter Klaus et al.   PEDIATRIC NEPHROLOGY

Familial hypercholesterolemia treatments: Guidelines and new therapies

(2018) Frederick J. Raal et al.   ATHEROSCLEROSIS

Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy

(2018) Marcio H. Miname et al.   JACC-Cardiovascular Imaging

Reclassifying Risk in Familial Hypercholesterolemia

(2018) Michael D. Shapiro et al.   JACC-Cardiovascular Imaging

Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: who does it in the world?

(2017) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Toward an international consensus—Integrating lipoprotein apheresis and new lipid-lowering drugs

(2017) Claudia Stefanutti et al.   Journal of Clinical Lipidology

Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia

(2017) G. Kees Hovingh et al.   Journal of Clinical Lipidology

Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations

(2017) Evan A. Stein et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom

(2016) Michael France et al.   ATHEROSCLEROSIS

ODYSSEY ESCAPE: is PCSK9 inhibition the Trojan Horse for the use of lipoprotein apheresis in familial hypercholesterolaemia?

(2016) Gerald F. Watts et al.   EUROPEAN HEART JOURNAL

Correlates of Achieving Statin Therapy Goals in Children and Adolescents with Dyslipidemia

(2016) Michael M. Mendelson et al.   JOURNAL OF PEDIATRICS

Child–Parent Familial Hypercholesterolemia Screening in Primary Care

(2016) David S. Wald et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ezetimibe: an update on its clinical usefulness in specific patient groups

(2016) Daniel Hammersley et al.   Therapeutic Advances in Chronic Disease

Homozygous autosomal dominant hypercholesterolaemia

(2015) Barbara Sjouke et al.   CURRENT OPINION IN LIPIDOLOGY

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

(2015) Albert Wiegman et al.   EUROPEAN HEART JOURNAL

Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia

(2015) D. Meeike Kusters et al.   JOURNAL OF PEDIATRICS

Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk

(2015) Marjet J.A.M. Braamskamp et al.   JOURNAL OF PEDIATRICS

Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease

(2015) Mohamad Alkhouli et al.   NEFROLOGIA

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

(2015) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lipoprotein Apheresis in the Management of Familial Hypercholesterolaemia: Historical Perspective and Recent Advances

(2014) Claudia Stefanutti et al.   Current Atherosclerosis Reports

Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome

(2014) Barbara Sjouke et al.   EUROPEAN HEART JOURNAL

Effect of a low-fat diet enriched either with rapeseed oil or sunflower oil on plasma lipoproteins in children and adolescents with familial hypercholesterolaemia. Results of a pilot study

(2014) L Negele et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Ten-Year Follow-up After Initiation of Statin Therapy in Children With Familial Hypercholesterolemia

(2014) D. Meeike Kusters et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

(2013) B. G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study

(2013) Philippa J Talmud et al.   LANCET

Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication

(2012) Marianne Benn et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

(2012) Marina Cuchel et al.   LANCET

Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy

(2011) Frederick J. Raal et al.   CIRCULATION

Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

(2011) Anne C. Goldberg et al.   Journal of Clinical Lipidology

LDL Apheresis in a Homozygous Familial Hypercholesterolemic Child Aged 4.5

(2010) C. Stefanutti et al.   ARTIFICIAL ORGANS

Traitement d’une hypercholestérolémie familiale homozygote par LDL-aphérèse chez un enfant de 4 ans

(2009) B. Lefort et al.   ARCHIVES DE PEDIATRIE

Low Density Lipoprotein Apheresis in Pediatric Patients With Homozygous Familial Hypercholesterolemia

(2009) Mahmut Coker et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Long-Term Safety and Efficacy of Low-Density Lipoprotein Apheresis in Childhood for Homozygous Familial Hypercholesterolemia

(2008) Lisa C. Hudgins et al.   AMERICAN JOURNAL OF CARDIOLOGY

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study

(2008) A. Neil et al.   EUROPEAN HEART JOURNAL

Efficacy and Safety of Coadministration of Ezetimibe and Simvastatin in Adolescents With Heterozygous Familial Hypercholesterolemia

(2008) Anouk van der Graaf et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Low-density Lipoprotein Apheresis in Children With Familial Hypercholesterolemia: Follow-up to 21 Years

(2008) Jean-Bernard Palcoux et al.   THERAPEUTIC APHERESIS AND DIALYSIS